Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Next Bristol/ImClone? “Standstill” Provisions Complicate Other Deals

Sep 08 2008

• By Michael McCaughan

Related Content

Lilly Brings Full Value Of Cialis In-House With Purchase Of Partner ICOS

Oct 23 2006

Change of Control: Why Getting it Right Matters Even More

Mar 01 2008

Adolor Seeks New Entereg Partner; Asks FDA To Weigh In On Chronic Use

Sep 02 2008

Byetta Scripts, LAR Progress Unaffected By Safety Scare, Amylin Says

Sep 01 2008

Bristol’s Proposed ImClone Acquisition May Beckon Potential Suitors

Aug 04 2008

Roche’s High Stakes Gambit For Genentech

Jul 28 2008

Pfizer Does Not Stand Still: AmericanWarner Break-Up Provision Is Hurdle

Nov 08 1999

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window